| Dina Y Gewaily, MD | |
|
2150 Harrisburg Pike, Ste 370, Lancaster, PA 17601-2644 | |
| (717) 399-8790 | |
| (717) 399-3279 |
| Full Name | Dina Y Gewaily |
|---|---|
| Gender | Female |
| Speciality | Ophthalmology |
| Experience | 15 Years |
| Location | 2150 Harrisburg Pike, Lancaster, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104054048 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207WX0107X | Ophthalmology - Retina Specialist | MD448335 (Pennsylvania) | Secondary |
| 207W00000X | Ophthalmology | MD448335 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lancaster General Hospital | Lancaster, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lancaster Retina Specialists Pc | 2466679634 | 4 |
News Archive
A novel approach to discover the first new tuberculosis (TB) combination drug regimen cleared a major hurdle when Phase II clinical trial results found it could kill more than 99 percent of patients' TB bacteria within two weeks and could be more effective than existing treatments, according to a study published today in the Lancet. These results add to a growing body of evidence that the new regimen could reduce treatment by more than a year for some patients.
Forensic Fluids Laboratories Inc., a leading provider of oral fluid drug testing, today announced that the company was named to the prestigious Inc. 500 list, a list of the most entrepreneurial and fastest growing companies in the United States. Forensic Fluids Lab was number 167 on the general list, number 10 in health care, number 2 in Michigan, and number 20 for women-owned.
The strongest predictors of guideline-compliant care of cancer patients with febrile neutropenia are the case volumes of the treating physicians and hospitals, a study shows.
Perrigo Company plc announced today that it has acquired the Mexican operations of Durham, North Carolina-based Patheon for $34 million in cash.
› Verified 4 days ago
| Entity Name | Lancaster Retina Specialists Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558785725 PECOS PAC ID: 2466679634 Enrollment ID: O20140812000736 |
News Archive
A novel approach to discover the first new tuberculosis (TB) combination drug regimen cleared a major hurdle when Phase II clinical trial results found it could kill more than 99 percent of patients' TB bacteria within two weeks and could be more effective than existing treatments, according to a study published today in the Lancet. These results add to a growing body of evidence that the new regimen could reduce treatment by more than a year for some patients.
Forensic Fluids Laboratories Inc., a leading provider of oral fluid drug testing, today announced that the company was named to the prestigious Inc. 500 list, a list of the most entrepreneurial and fastest growing companies in the United States. Forensic Fluids Lab was number 167 on the general list, number 10 in health care, number 2 in Michigan, and number 20 for women-owned.
The strongest predictors of guideline-compliant care of cancer patients with febrile neutropenia are the case volumes of the treating physicians and hospitals, a study shows.
Perrigo Company plc announced today that it has acquired the Mexican operations of Durham, North Carolina-based Patheon for $34 million in cash.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dina Y Gewaily, MD 2150 Harrisburg Pike, Ste 370, Lancaster, PA 17601-2644 Ph: (717) 399-8790 | Dina Y Gewaily, MD 2150 Harrisburg Pike, Ste 370, Lancaster, PA 17601-2644 Ph: (717) 399-8790 |
News Archive
A novel approach to discover the first new tuberculosis (TB) combination drug regimen cleared a major hurdle when Phase II clinical trial results found it could kill more than 99 percent of patients' TB bacteria within two weeks and could be more effective than existing treatments, according to a study published today in the Lancet. These results add to a growing body of evidence that the new regimen could reduce treatment by more than a year for some patients.
Forensic Fluids Laboratories Inc., a leading provider of oral fluid drug testing, today announced that the company was named to the prestigious Inc. 500 list, a list of the most entrepreneurial and fastest growing companies in the United States. Forensic Fluids Lab was number 167 on the general list, number 10 in health care, number 2 in Michigan, and number 20 for women-owned.
The strongest predictors of guideline-compliant care of cancer patients with febrile neutropenia are the case volumes of the treating physicians and hospitals, a study shows.
Perrigo Company plc announced today that it has acquired the Mexican operations of Durham, North Carolina-based Patheon for $34 million in cash.
› Verified 4 days ago
John William Sharp Jr., MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1254 Lititz Pike, Lancaster, PA 17601 Phone: 717-397-4724 Fax: 717-397-6687 | |
William M Spitler Iii, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 2108 Harrisburg Pike, Ste 100, Lancaster, PA 17601 Phone: 717-544-3900 Fax: 717-544-3910 | |
Dr. Patrick T Tiedeken, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2170 Noll Dr Ste 400, Lancaster, PA 17603 Phone: 717-417-8950 | |
Dr. Justin L Cappiello, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 324 N Duke St, Lancaster, PA 17603 Phone: 717-394-6808 Fax: 717-299-4133 | |
Adam Ryan Thode, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2115 Noll Dr, Lancaster, PA 17603 Phone: 717-393-7980 Fax: 717-509-5079 | |
Pierre K Palandjian, D.O. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1254 Lititz Pike, Lancaster, PA 17601 Phone: 717-397-4724 Fax: 717-397-6687 |